The Translational Initiative to Map Epigenetics in Aging (TIME-A)
ConditionBiological Aging
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorElysium Health
About this trial
The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.
Eligibility criteria
Qualifiers
All adults aged 18 and above
Have registered at least one Index kit via the Elysium Health website
Able and willing to provide digital consent to the Research Consent Form, and the TIME-A Research Subject Consent Form
Disqualifiers
Consent to participate not given
Trial design
Treatments tested in this trial
- Not listed
Trial groups
25,000 Participants
are grouped into 1 trial groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov